Havana, Cuba

Blanca Idelmis Tolón Murguía


Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Blanca Idelmis Tolón Murguía

Introduction

Blanca Idelmis Tolón Murguía, a distinguished inventor based in Havana, Cuba, has made significant strides in the field of immunology. With a focus on vaccine development, her work centers around enhancing immune responses through innovative nanoparticle technology.

Latest Patents

Tolón Murguía holds a notable patent for her invention titled "Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccines." This invention details methods for creating nano-particulated adjuvants that comprise synthetic variants of GM3 ganglioside. These adjuvants are engineered to stimulate both humoral and cellular immune responses against targeted antigens, highlighting the sophisticated nature of her work. The patent includes immunogenic vaccine compositions that integrate peptides, polypeptides, or proteins alongside these nanoparticles. These nanoparticles are developed through the dispersion of hydrophobic proteins sourced from the outer membrane complex within solutions of fully synthetic GM3 ganglioside variants.

Career Highlights

Blanca Idelmis Tolón Murguía is affiliated with the Centro de Inmunología Molecular, where she conducts groundbreaking research in vaccine technology. Her dedication to advancing immunological science has placed her at the forefront of innovations that can potentially revolutionize vaccine efficacy and safety.

Collaborations

Throughout her career, Tolón Murguía has collaborated with notable colleagues, including Luis Enrique Fernández Molina and Belinda Sánchez Ramírez. These partnerships contribute to a rich collaborative environment that fosters innovative ideas and research advancements.

Conclusion

In summary, Blanca Idelmis Tolón Murguía is a prominent figure in the field of immunology, known for her impactful invention involving nanoparticle adjuvants. Her contributions not only enhance the scientific community's understanding of vaccine technology but also represent significant progress in the fight against infectious diseases. Her ongoing work at the Centro de Inmunología Molecular is poised to influence future developments in immunization strategies globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…